Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Autoimmun intervensjon Mestringskurs Studie (AIM)

15. september 2026 oppdatert av: Terry L. Wahls

Evaluering av et nettkurs designet for å støtte innføringen av sunnere kosthold og egenomsorgsrutiner hos pasienter med multippel sklerose

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.

Studieoversikt

Detaljert beskrivelse

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remissin with persisting fatigue. The cancer patients must be patients at the University of Iowa Holden Cancer Center.

Once eligibility criteria are determined and consent is obtained, participants would work through the course modules like a non-graded online course. There are exercises and personal assessments within the course participants are asked to take to build upon each other to increase the success of the experience while taking the course.

Throughout the course there will be modules that will discuss an inner game plan, food intervention plan, physical intervention plan, and an increased resilience plan. The fourth module suggests different strategies that participants can do to improve their health beyond food and exercise. These types of things would include supplements, light therapy, detoxification, improved sleep, stress reduction, and other ways to enhance their body's resilience.

Investigators ask that participants inform and work with their healthcare team to personalize their treatment and determine if the suggested strategies mentioned in the course are appropriate for their healthcare path. This will provide dietary education to a larger sample size compared to what has been studied in the past. The study may include more patients that have limited resources, including but not limited to, money and location for access to registered dietitians with expertise in dietary instruction for patient s diagnosed with multiple sclerosis and CIS. There is interest in education and support that can be delivered via an online platform that can lead to improved diet quality and self-care routines for multiple sclerosis and autoimmune patients.

This study will use a randomized single-blind wait list control design to evaluate the impact of an online course that teaches the modified Paleolithic diet, nutrient dense vegetarian diet and Mediterranean diets, stress reduction and exercise strategies using commercially available online course for autoimmune patients. Data will be collected in the short-term (after 3 months) and long-term (at the end of 6 months ) to analyze the impact of an online wellness program QoL and related outcomes among people with CIS and MS, fibromyalgia, post acute sequela of covid, and cancer in remission wiht persisting fatigue.

The study will use a 7-day window to collect baseline assessments. Participants will use a personal email that does not contain identifying information to participate in the study. Participants will be asked to complete all baseline assessments. This email and password will be used for access to the online course materials. Patients will be randomized to the intervention arm based upon the baseline modified fatigue impact score.

Patients will receive access to the online program and 7 group support videos (released one per week or 7 weeks total). Participants will access the course materials using the study assigned email.

The proposed study will consist of virtual-only participants and will have 3 virtual visits every 3 months (months 0, 3, and 6). Online questionnaires will be sent to the participants to assess fatigue and quality of life. Dietary assessments will include a questionnaire through a web-based tool after baseline, at month 3, and month 6.

Studietype

Intervensjonell

Registrering (Antatt)

400

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Iowa
      • Iowa City, Iowa, Forente stater, 52246
        • Univeristy of Iowa

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 100 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • self-reported multiple sclerosis
  • self-reported clinically isolated syndrome

OR self-reported post-acute sequelae of COVID (PASC), also known as long COVID, with a confirmed laboratory test of COVID-19 infection, persisting fatigue and neuropsychiatric symptoms for longer than 6 months after confirmation of COVID diagnosis,

OR self-reported diagnosis of fibromyalgia as documented by their treating specialist or primary care provider,

Exclusion Criteria:

-

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Intervention Autoimmune Intervention Mastery Course (AIM) online course

This arm will begin the intervention immediately after randomization

Immediate access to an on line audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care

Andre navn:
  • AIM kurs

Immediate access to videos answering common questions about the course concepts. One video released each week, 7 videos total.

Andre navn:
  • AIM Q og A økter
Annen: Delayed Autoimmune Intervention Mastery Course

This is the control arm.

Delayed access to an on line audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care

Delayed access to videos answering common questions about the course concepts. One video released each week, 7 videos total.

Andre navn:
  • Forsinkede AIM Q og A økter

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Multiple Sclerosis 54 Quality of Life Mental Health (MS 54 QoL MH)
Tidsramme: baseline to 3 months

Change in (MS 54 QoL MH) survey questions mean scores, range 0-100, higher number is better.

baseline to 3 months
Multiple Sclerosis 54 Quality of Life Mental Health (MS 54 QoL MH)
Tidsramme: baseline to 6months

Change in (MS 54 QoL MH) survey questions mean scores, range 0-100, higher number is better.

baseline to 6months
Multiple Sclerosis 54 Quality of Life Physical Health (MS 54 QoL PH)
Tidsramme: baseline to 3 months

Change in (MS 54 QoL PH) survey questions mean scores, range 0-100, higher number is better.

baseline to 3 months
Multiple Sclerosis 54 Quality of Life Physical Health (MS 54 QoL PH)
Tidsramme: baseline to 6 months

Change in (MS 54 QoL PH) survey questions mean scores, range 0-100, higher number is better.

baseline to 6 months
Short form 36 (SF 36)
Tidsramme: baseline to 3 months

Change in (SF 36) survey questions mean scores, range 0-100, higher number is better.

baseline to 3 months
Short form 36 (SF 36)
Tidsramme: baseline to 6 months

Change in (SF 36) survey questions mean scores, range 0-100, higher number is better.

baseline to 6 months
The Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-FS):
Tidsramme: baseline to 3 months

FACIT-FS is a 13-item measure that assesses self-reported fatigue and its impact upon daily activities and function, which can be completed in less than 5 minutes.10 Each question provides 5 ordinal response options ("not at all," "a little bit," "somewhat," "quite a bit," and "very much"). Each item contributes equally (item score range=0-4) to a total score that ranges from 0 to 52, where higher scores represent less fatigue.

baseline to 3 months
The Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-FS):
Tidsramme: baseline to 6 months

FACIT-FS is a 13-item measure that assesses self-reported fatigue and its impact upon daily activities and function, which can be completed in less than 5 minutes.10 Each question provides 5 ordinal response options ("not at all," "a little bit," "somewhat," "quite a bit," and "very much"). Each item contributes equally (item score range=0-4) to a total score that ranges from 0 to 52, where higher scores represent less fatigue.

baseline to 6 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Modified Fatigue Impact Scale
Tidsramme: baseline to 3 months

Change in MFIS survey questions, scores range from 0-84, lower score is better.

baseline to 3 months
Modified Fatigue Impact Scale
Tidsramme: baseline to 6 months

Change in MFIS survey questions, scores range from 0-84, lower score is better.

baseline to 6 months
vegetable and fruit intake
Tidsramme: baseline to 3 months

Change in number of servings of vegetables consumed per day, servings range from 0 to 9 or more

baseline to 3 months
vegetable and fruit intake
Tidsramme: baseline to 6 months

Change in number of servings of vegetables consumed per day, servings range from 0 to 9 or more

baseline to 6 months
added sugar intake
Tidsramme: baseline to 3 months

change in the grams of added sugar consumed each day, grams range from 0 to 100

baseline to 3 months
added sugar intake
Tidsramme: baseline to 6 months

change in the grams of added sugar consumed each day, grams range from 0 to 100

baseline to 6 months
calcium intake
Tidsramme: baseline to 3 months

change in calcium intake, range 0 to 2000 mg

baseline to 3 months
calcium intake
Tidsramme: baseline to 6 months

change in calcium intake, range 0 to 2000 mg

baseline to 6 months
Servings of whole grains consumed
Tidsramme: baseline to 3 months

change in number of servings of whole grains consumed, range 0 to 6 or more servings

baseline to 3 months
Servings of whole grains consumed
Tidsramme: baseline to 6 months

change in number of servings of whole grains consumed, range 0 to 6 or more servings

baseline to 6 months
Fibromyalgia Impact Questionnaire Revised
Tidsramme: baseline to 3 months

Pain Rating (0-10 Low to High Scale) survey questions with higher score indicating greater impact

baseline to 3 months
Fibromyalgia Impact Questionnaire Revised
Tidsramme: baseline to 6 months

Pain Rating (0-10 Low to High Scale) survey with 15 items with higher score indicating greater impact

baseline to 6 months
Brief Pain Inventory
Tidsramme: baseline to 3 months

Interference (0-10 Low to High Scale) 15 survey items with higher score indicating greater intensity

baseline to 3 months
Brief Pain Inventory
Tidsramme: baseline to 6 months

Range 0-10(Low to High Scale) survey with higher score indicating greater pain intensity

baseline to 6 months
FM Disease activity (FIQR)
Tidsramme: baseline to 3 months

0-100( Low to High Scale)21 survey items used to evaluate function, overall impact, and symptoms in patients with fibromyalgia.

baseline to 3 months
FM Disease activity (FIQR)
Tidsramme: baseline to 6 months

0-100 (Low to High Scale)21 survey items used to evaluate function, overall impact, and symptoms in patients with fibromyalgia. High score indicating more severe symptoms.

baseline to 6 months
Pain scale
Tidsramme: baseline to 3 months

0-10 (low to high) 13 survey items used to evaluate feelings about pain.

baseline to 3 months
Pain catastrophizing scale
Tidsramme: baseline to 6 months

052 (low to high) 13 survey items used to evaluate feelings about pain. Higher scores indicating more severe feelings about pain related problems

baseline to 6 months
Functional Assessment of Cancer Therapy - General (FACT-G)
Tidsramme: baseline to 3 months

measures health-related QoL covering 5 domains: physical well-being (7 items), family/social well-being (7 items), emotional well-being (6 items), functional well-being (7 items), and fatigue-specific items (13 items).10 These items are scored on a 5-point Likert scale, where 0 = "not at all" and 5 = "very much," with a recall period over the past 7 days. Domain scores can be calculated by summing the scores for each domain, and/or a total score by summing the scores for all domains, with higher scores representing better functioning. General guidelines estimate for the FACT-G minimally important difference (MID), is 4-7 points. The total score ranges from 0-108.

baseline to 3 months
Functional Assessment of Cancer Therapy - General (FACT-G)
Tidsramme: baseline to 6 months

measures health-related QoL covering 5 domains: physical well-being (7 items), family/social well-being (7 items), emotional well-being (6 items), functional well-being (7 items), and fatigue-specific items (13 items).10 These items are scored on a 5-point Likert scale, where 0 = "not at all" and 5 = "very much," with a recall period over the past 7 days. Domain scores can be calculated by summing the scores for each domain, and/or a total score by summing the scores for all domains, with higher scores representing better functioning. General guidelines estimate for the FACT-G minimally important difference (MID), is 4-7 points. The total score ranges from 0-108.

baseline to 6 months
Optional interview at study conclusion
Tidsramme: collected at study conclusion

Asking open ended questions about the participant's study experience, barriers, challenges, web-based aspect of course, social support, geographic location, experience with specific modules and suggestions for improvement for the course and the study

collected at study conclusion

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Hovedetterforsker: Terry L Wahls, MD, University of Iowa

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. desember 2021

Primær fullføring (Antatt)

1. desember 2027

Studiet fullført (Antatt)

1. desember 2027

Datoer for studieregistrering

Først innsendt

15. september 2021

Først innsendt som oppfylte QC-kriteriene

15. september 2021

Først lagt ut (Faktiske)

27. september 2021

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

15. september 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Will share study data to scientists with a published PROSPERO registered meta-analysis.

IPD-delingstidsramme

A year after the data has been published.

Tilgangskriterier for IPD-deling

Scientists with a published (in a peer reviewed journal) PROSPERO meta-analysis protocol who have contacted the PI with a copy of the published protocol, their address, phone number and specific data that is being requested. The PI will review the documents and if determined appropriate, the PI will then initiate an outgoing material data use agreement with the Division of Sponsored Programs at the University of Iowa who will then contact the requesting scientist. Once the date use agreement has been signed, the data will be shared according to the terms outlined in the data use agreement.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • ICF

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere